Class 3 Medicines Recall: GoResp Digihaler (Teva UK Ltd) Drug alert number: EL (24)A/23 Date issued: 18 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for GoResp Digihaler (Teva UK Ltd). Company name: Teva UK Ltd Product name: GoResp Digihaler, PLGB 00289/2501 SNOMED Code: 42007211000001108 Batch Number
Read morePharmacy owners across the North East are invited to meet the Community Pharmacy England team to discuss the issues that matter to you. Chief Executive Janet Morrison and the team are heading to Newcastle on the evening of Wednesday 3rd July to talk directly to local pharmacy owners. Our regional roadshow will outline all of
Read moreBy Chief Executive Janet Morrison It’s hard to believe that we’re already more than half-way through a six-week General Election campaign. And as the intensity of politicians’ debate increases now that the manifestos are public knowledge, so too are the efforts to get community pharmacy talked about on the doorstep – and to prepare for
Read moreClass 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Drug alert number: EL (24)A/22 Date issued: 17 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Company name: Viatris UK Healthcare
Read moreThe participation period for our Pharmacy Advice Audit has been extended to Friday 28th June. Whilst there has been an encouraging submission rate so far, we would like to increase this figure to ensure that the audit results have as much impact as they can. Recognising how busy community pharmacy teams are at the moment, we
Read morePharmacy teams are reminded that they don’t have long left to complete our Pharmacy Advice Audit. The audit will provide critical evidence for use in our ongoing call for more funding, as well as information to support our wider advocacy work and help to continue to make the case for the sector. Your participation will
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Erythromycin 250mg gastro-resistant tablets MSN/2024/071 Tier 2 – medium impact Date of issue: 12th June 2024 Erythromycin 250mg tablets are currently out of stock until w/c 24th of June 2024. Erythromycin 500mg tablets remain available but are unable to support an
Read moreClass 4 Medicines Defect Information: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited) Drug alert number: EL (24)A/21 Date issued: 10 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited) Company name: Dawa Limited Product name: Paracetamol
Read moreWe are asking as many community pharmacy teams as possible to take part in our Pharmacy Advice Audit before 16th June 2024. The audit aims to help demonstrate how pharmacies are supporting their communities every day and provide critical evidence for use in our ongoing call for more funding. Your participation will also help us
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomil® XL 60mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP059 Monomil® XL 60mg tablets expires at 23.59pm on Friday 7 June 2024. After this date, any prescriptions for Monomil® XL 60mg
Read more
